
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer
Rama Rao Malla, Mundla Srilatha, Batoul Farran, et al.
Molecular Therapy (2023) Vol. 32, Iss. 1, pp. 13-31
Open Access | Times Cited: 15
Rama Rao Malla, Mundla Srilatha, Batoul Farran, et al.
Molecular Therapy (2023) Vol. 32, Iss. 1, pp. 13-31
Open Access | Times Cited: 15
Showing 15 citing articles:
A new era of cancer immunotherapy: vaccines and miRNAs
Gitika Sareen, Maneesh Mohan, Ashi Mannan, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access | Times Cited: 2
Gitika Sareen, Maneesh Mohan, Ashi Mannan, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access | Times Cited: 2
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Novel Strategies in Breast Cancer Management: from Treatment to Long-term Remission
S Habibi, Shabbou Bahramian, Saeedeh Zare Jalise, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104715-104715
Closed Access | Times Cited: 1
S Habibi, Shabbou Bahramian, Saeedeh Zare Jalise, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104715-104715
Closed Access | Times Cited: 1
The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2
Yuan Hu, Lili Liu, Shenghua Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 5, pp. 5175-5192
Open Access | Times Cited: 6
Yuan Hu, Lili Liu, Shenghua Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 5, pp. 5175-5192
Open Access | Times Cited: 6
mRNA-based vaccines – global approach, challenges, and could be a promising wayout for future pandemics
Shivani Makhijani, Gehan M. Elossaily, Satish Rojekar, et al.
Pharmaceutical Development and Technology (2024) Vol. 29, Iss. 6, pp. 559-565
Closed Access | Times Cited: 6
Shivani Makhijani, Gehan M. Elossaily, Satish Rojekar, et al.
Pharmaceutical Development and Technology (2024) Vol. 29, Iss. 6, pp. 559-565
Closed Access | Times Cited: 6
Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials
Rama Rao Malla, Mundla Srilatha, Veda Muppala, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 707-720
Closed Access | Times Cited: 4
Rama Rao Malla, Mundla Srilatha, Veda Muppala, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 707-720
Closed Access | Times Cited: 4
Leveraging high-throughput screening technologies in targeted mRNA delivery
Yuchen Zhang, Zhifei Gao, Xiao Yang, et al.
Materials Today Bio (2024) Vol. 26, pp. 101101-101101
Open Access | Times Cited: 4
Yuchen Zhang, Zhifei Gao, Xiao Yang, et al.
Materials Today Bio (2024) Vol. 26, pp. 101101-101101
Open Access | Times Cited: 4
The inorganic pyrophosphatases of microorganisms: a structural and functional review
Rodolfo García‐Contreras, Javier Mora, Héctor M. Mora‐Montes, et al.
PeerJ (2024) Vol. 12, pp. e17496-e17496
Open Access | Times Cited: 4
Rodolfo García‐Contreras, Javier Mora, Héctor M. Mora‐Montes, et al.
PeerJ (2024) Vol. 12, pp. e17496-e17496
Open Access | Times Cited: 4
Nanoparticles for mRNA-based cancer immunotherapy
Rakesh Pahwa, Gulshan Sharma, Rohil Panwar, et al.
Advances in immunology (2025)
Closed Access
Rakesh Pahwa, Gulshan Sharma, Rohil Panwar, et al.
Advances in immunology (2025)
Closed Access
An mRNA vaccine encoding proteasome-targeted antigen enhances CD8+ T cell immunity
Ling Jin, Hongwei Chen, Mengwen Huang, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113578-113578
Closed Access
Ling Jin, Hongwei Chen, Mengwen Huang, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113578-113578
Closed Access
Neoantigen-based mRNA vaccine exhibits superior anti-tumor activity compared to synthetic long peptides in an in vivo lung carcinoma model
Cao Minh Nguyen, Trung Vu, Minh Nguyen Nguyen, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
Cao Minh Nguyen, Trung Vu, Minh Nguyen Nguyen, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
Alireza Shariati, Pouria Khani, Farzad Nasri, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Alireza Shariati, Pouria Khani, Farzad Nasri, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Machine Learning and Deep Learning Strategies for Chinese Hamster Ovary Cell Bioprocess Optimization
Tiffany-Marie D. Baako, S Kulkarni, Jerome McClendon, et al.
Fermentation (2024) Vol. 10, Iss. 5, pp. 234-234
Open Access | Times Cited: 1
Tiffany-Marie D. Baako, S Kulkarni, Jerome McClendon, et al.
Fermentation (2024) Vol. 10, Iss. 5, pp. 234-234
Open Access | Times Cited: 1
Applications of Novel Microscale and Nanoscale Materials for Theranostics: From Design to Clinical Translation
Mengxiang Tian, Bingzhi Dong, Weiqi Li, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1339-1339
Open Access | Times Cited: 1
Mengxiang Tian, Bingzhi Dong, Weiqi Li, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1339-1339
Open Access | Times Cited: 1